Market closedNon-fractional
Chemed/CHE
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Chemed
Chemed Corp operates subsidiaries in two main segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue. It provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The vast majority of the segment's revenue is received from the Medicare and Medicaid reimbursement programs. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers. Chemed generates the majority of its revenue from business in the United States.
Ticker
CHE
Sector
Healthcare
Trading on
NYSE
Industry
Health Care Providers and Services
Headquarters
Cincinnati, United States
Employees
15,087
Website
www.chemed.com
Chemed Metrics
BasicAdvanced
$8.2B
Market cap
27.44
P/E ratio
$19.72
EPS
0.43
Beta
$1.60
Dividend rate
0.30%
Dividend yield
Price and volume
Market cap
$8.2B
Beta
0.43
Dividend rate
$1.60
Financial strength
Current ratio
1.775
Quick ratio
1.558
Long term debt to equity
8.716
Total debt to equity
12.126
Dividend payout ratio (TTM)
8.04%
Interest coverage (TTM)
220.10%
Management effectiveness
Return on assets (TTM)
13.93%
Return on equity (TTM)
27.87%
Valuation
Price to earnings (TTM)
27.435
Price to revenue (TTM)
3.497
Price to book
6.8
Price to tangible book (TTM)
18.33
Price to free cash flow (TTM)
32.296
Dividend yield (TTM)
0.30%
Growth
Revenue change (TTM)
6.79%
Earnings per share change (TTM)
31.50%
3-year revenue growth (CAGR)
3.26%
3-year earnings per share growth (CAGR)
1.90%
3-year dividend per share growth (CAGR)
5.57%
What the Analysts think about Chemed
Analyst Ratings
Majority rating from 3 analysts.
Chemed Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$589M
0.56%
Net income
$65M
-27.78%
Profit margin
11.03%
-28.19%
Chemed Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$4.71
$5.32
$6.60
$5.20
-
Expected
$5.09
$4.90
$6.25
$5.48
$5.59
Surprise
-7.40%
8.57%
5.60%
-5.11%
-
Chemed News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Chemed stock?
Chemed (CHE) has a market cap of $8.2B as of July 27, 2024.
What is the P/E ratio for Chemed stock?
The price to earnings (P/E) ratio for Chemed (CHE) stock is 27.44 as of July 27, 2024.
Does Chemed stock pay dividends?
Yes, the Chemed (CHE) stock pays dividends to shareholders. As of July 27, 2024, the dividend rate is $1.6 and the yield is 0.3%. Chemed has a payout ratio of 8.04% on a trailing twelve-month basis.
When is the next Chemed dividend payment date?
The next Chemed (CHE) dividend payment date is unconfirmed.
What is the beta indicator for Chemed?
Chemed (CHE) has a beta rating of 0.43. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Chemed stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.